Literature DB >> 21670742

AKNA: another AT-hook transcription factor "hooking-up" with inflammation.

Alison R Moliterno1, Linda M S Resar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21670742      PMCID： PMC3365640          DOI： 10.1038/cr.2011.96

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  17 in total

1.  HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.

Authors:  Siong-Seng Liau; Amarsanaa Jazag; Edward E Whang
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

2.  Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome.

Authors:  Lois Beckerbauer; Jetze J Tepe; Rebecca A Eastman; Philip F Mixter; Robert M Williams; Raymond Reeves
Journal:  Chem Biol       Date:  2002-04

3.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

4.  Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA.

Authors:  A Siddiqa; J C Sims-Mourtada; L Guzman-Rojas; R Rangel; C Guret; V Madrid-Marina; Y Sun; H Martinez-Valdez
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

5.  The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

Authors:  S Battista; V Fidanza; M Fedele; A J Klein-Szanto; E Outwater; H Brunner; M Santoro; C M Croce; A Fusco
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

6.  The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

Authors:  Abeba Tesfaye; Francescopaolo Di Cello; Joelle Hillion; Brigitte M Ronnett; Ossama Elbahloul; Raheela Ashfaq; Surajit Dhara; Edward Prochownik; Kathryn Tworkoski; Raymond Reeves; Richard Roden; Lora Hedrick Ellenson; David L Huso; Linda M S Resar
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

Review 7.  Roles of HMGA proteins in cancer.

Authors:  Alfredo Fusco; Monica Fedele
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

8.  Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C.

Authors:  X Zhou; K F Benson; H R Ashar; K Chada
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

9.  High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells.

Authors:  Natsuki Takaha; Linda M S Resar; Don Vindivich; Donald S Coffey
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

10.  Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas.

Authors:  P Arlotta; A K Tai; G Manfioletti; C Clifford; G Jay; S J Ono
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157
View more
  15 in total

Review 1.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

2.  Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Authors:  Breann L Yanagisawa; Linda M S Resar
Journal:  Expert Rev Anticancer Ther       Date:  2014-01       Impact factor: 4.512

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

Authors:  Joelle Hillion; Shamayra S Smail; Francescopaolo Di Cello; Amy Belton; Sandeep N Shah; Tait Huso; Andrew Schuldenfrei; Dwella Moton Nelson; Leslie Cope; Nathaniel Campbell; Collins Karikari; Abimbola Aderinto; Anirban Maitra; David L Huso; Linda M S Resar
Journal:  Pancreatology       Date:  2012-05-29       Impact factor: 3.996

5.  Cervical cancer-associated promoter polymorphism affects akna expression levels.

Authors:  G A Martínez-Nava; K Torres-Poveda; A Lagunas-Martínez; M Bahena-Román; M A Zurita-Díaz; E Ortíz-Flores; A García-Carrancá; V Madrid-Marina; A I Burguete-García
Journal:  Genes Immun       Date:  2014-11-06       Impact factor: 2.676

6.  Exome sequencing in genomic regions related to racing performance of Quarter Horses.

Authors:  Guilherme L Pereira; Jessica M Malheiros; Alejandra M T Ospina; Luis Artur L Chardulo; Rogério A Curi
Journal:  J Appl Genet       Date:  2019-01-21       Impact factor: 3.240

7.  HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.

Authors:  Sandeep N Shah; Candace Kerr; Leslie Cope; Elias Zambidis; Cyndi Liu; Joelle Hillion; Amy Belton; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

8.  RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection.

Authors:  Neven Papic; Christopher I Maxwell; Don A Delker; Shuanghu Liu; Bret S E Heale; Curt H Hagedorn
Journal:  Viruses       Date:  2012-04-16       Impact factor: 5.048

9.  HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.

Authors:  Amy Belton; Alexander Gabrovsky; Young Kyung Bae; Ray Reeves; Christine Iacobuzio-Donahue; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

10.  HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.

Authors:  Andrew Schuldenfrei; Amy Belton; Jeanne Kowalski; C Conover Talbot; Francescopaolo Di Cello; Weijie Poh; Hua-Ling Tsai; Sandeep N Shah; Tait H Huso; David L Huso; Linda M S Resar
Journal:  BMC Genomics       Date:  2011-11-04       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.